Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa.
出版信息
Afr Health Sci. 2001 Aug;1(1):30-1.
Abstract
摘要
相似文献
1
2
Africa: children's access to prophylaxis may improve after medical study, new WHO recommendations.
AIDS Treat News. 2004 Nov-Dec(407-408):8-9.
3
Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection.重新考虑对暴露于艾滋病毒感染的婴儿进行复方新诺明经验性预防。
Bull World Health Organ. 2004 Apr;82(4):290-7.
4
Cotrimoxazole prophylaxis for infants exposed to HIV infection.对暴露于艾滋病毒感染的婴儿进行复方新诺明预防治疗。
Bull World Health Organ. 2004 Apr;82(4):297-8.
5
Cotrimoxazole prophylaxis for HIV-positive TB patients in developing countries.发展中国家艾滋病毒阳性结核病患者的复方新诺明预防治疗
Trop Doct. 2006 Apr;36(2):79-82. doi: 10.1258/004947506776593314.
6
7
Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations.编辑回应：卡氏肺孢子虫肺炎的预防——两个群体不断演变的故事。
Clin Infect Dis. 1999 Oct;29(4):784-6. doi: 10.1086/520434.
8
Protect yourself from Pneumocystis carinii.预防卡氏肺孢子虫感染。
AIDS Alert. 1999 Jun;14(6):suppl 1-2.
9
Discontinuing prophylaxis against Pneumocystis carinii pneumonia.停止针对卡氏肺孢子虫肺炎的预防措施。
N Engl J Med. 2001 May 24;344(21):1639; author reply 1640-1.
10
Pneumocystis jiroveci pneumonia in AIDS patients: reactivation, reinfection or both?
Int J STD AIDS. 2003 Sep;14(9):644-5. doi: 10.1258/095646203322301176.
引用本文的文献
1
Neonates exposed to HIV but uninfected exhibit an altered gut microbiota and inflammation associated with impaired breast milk antibody function.暴露于HIV但未感染的新生儿表现出肠道微生物群改变以及与母乳抗体功能受损相关的炎症。
Microbiome. 2024 Dec 20;12(1):261. doi: 10.1186/s40168-024-01973-z.
2
Reasons for implementation success despite health system constraints: qualitative insights on 'what worked' for cotrimoxazole preventive therapy.尽管存在卫生系统限制，但实施成功的原因：对复方新诺明预防治疗“有效因素”的定性见解。
BMC Health Serv Res. 2024 Mar 27;24(1):379. doi: 10.1186/s12913-024-10631-x.
3
Co-trimoxazole prophylaxis for children who are HIV-exposed and uninfected: a systematic review.HIV 暴露但未感染儿童的复方磺胺甲噁唑预防：系统评价。
J Int AIDS Soc. 2023 Jun;26(6):e26079. doi: 10.1002/jia2.26079.
4
Clinicopathological correlation of kidney disease in HIV infection pre- and post-ART rollout.在抗逆转录病毒疗法（ART）推出前后，HIV 感染相关肾脏病的临床病理相关性。
PLoS One. 2022 May 31;17(5):e0269260. doi: 10.1371/journal.pone.0269260. eCollection 2022.
5
Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid-Preventive therapies for people living with HIV.混合方法系统评价和荟萃分析，探讨了在艾滋病毒感染者中实施复方新诺明和异烟肼预防性治疗的障碍和促进因素。
PLoS One. 2022 Mar 1;17(3):e0251612. doi: 10.1371/journal.pone.0251612. eCollection 2022.
6
Types and prevalence of HIV-related opportunistic infections/conditions among HIV-positive patients attending Kenyatta National Hospital in Nairobi, Kenya.肯尼亚内罗毕肯雅塔国家医院的HIV阳性患者中与HIV相关的机会性感染/病症的类型及流行情况。
Afr Health Sci. 2020 Jun;20(2):615-624. doi: 10.4314/ahs.v20i2.9.
7
Use of non-HIV medication among people living with HIV and receiving antiretroviral treatment in Côte d'Ivoire, West Africa: A cross-sectional study.在西非科特迪瓦，接受抗逆转录病毒治疗的艾滋病毒感染者中使用非艾滋病毒药物：一项横断面研究。
PLoS One. 2019 Sep 16;14(9):e0221335. doi: 10.1371/journal.pone.0221335. eCollection 2019.
8
AIDS and tuberculosis in medical inpatients in Malawi.马拉维住院患者中的艾滋病与结核病
Malawi Med J. 2002 Sep;14(2):19-20. doi: 10.4314/mmj.v14i2.10762.
9
Evaluation of cotrimoxazole use as a preventive therapy among patients living with HIV/AIDS in Gondar University Referral Hospital, northwestern Ethiopia: a retrospective cross-sectional study.埃塞俄比亚西北部贡德尔大学转诊医院对感染艾滋病毒/艾滋病患者使用复方新诺明作为预防性治疗的评估：一项回顾性横断面研究。
HIV AIDS (Auckl). 2016 Jul 7;8:125-33. doi: 10.2147/HIV.S103081. eCollection 2016.
10
CD14(+) macrophages that accumulate in the colon of African AIDS patients express pro-inflammatory cytokines and are responsive to lipopolysaccharide.在非洲艾滋病患者结肠中积聚的CD14(+)巨噬细胞表达促炎细胞因子，并对脂多糖有反应。
BMC Infect Dis. 2015 Oct 17;15:430. doi: 10.1186/s12879-015-1176-5.
Zotero 插件